HCA Healthcare, Inc. $HCA Position Cut by Wealthfront Advisers LLC

Wealthfront Advisers LLC lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 16.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 25,204 shares of the company’s stock after selling 5,099 shares during the quarter. Wealthfront Advisers LLC’s holdings in HCA Healthcare were worth $11,928,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of HCA. Holos Integrated Wealth LLC bought a new position in HCA Healthcare in the 4th quarter valued at about $29,000. Palisade Asset Management LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter worth approximately $26,000. Ares Financial Consulting LLC acquired a new position in shares of HCA Healthcare during the fourth quarter valued at approximately $31,000. Cedar Mountain Advisors LLC acquired a new stake in HCA Healthcare in the first quarter worth approximately $33,000. Finally, MCF Advisors LLC increased its position in shares of HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after purchasing an additional 49 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of several research reports. Leerink Partners decreased their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Wells Fargo & Company cut their price target on shares of HCA Healthcare from $436.00 to $428.00 and set an “equal weight” rating for the company in a report on Monday, July 13th. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a report on Tuesday, July 7th. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a report on Wednesday. Finally, Robert W. Baird dropped their price target on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Fourteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $486.14.

HCA Healthcare Price Performance

Shares of HCA opened at $371.60 on Friday. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The company has a 50-day moving average of $392.25 and a two-hundred day moving average of $457.05. The stock has a market cap of $82.44 billion, a price-to-earnings ratio of 12.78, a PEG ratio of 1.27 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the company posted $6.45 EPS. The firm’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 29.74 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were issued a $0.78 dividend. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.